Qualys, Inc.
$5.78B- Market cap
- $5.94B
- Debt
- +$95.20M
- Cash
- −$250.26M
Capital structure 98% equity / 2% debt · EV / Revenue 8.64x · EV / EBITDA 23.19x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $5.94B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 · Mkt cap
Decision snapshot: QLYS stock price at premium vs JNJ $171.65 current versus $135.74 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at JNJ's multiple
Implied fair value · at QLYS's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Premium justified
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: QLYS FY 2025 (ended Dec 31, 2025) · JNJ FY 2025 (ended Dec 28, 2025). Fiscal years are not aligned.
Trendline
Nine fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 98% equity / 2% debt · EV / Revenue 8.64x · EV / EBITDA 23.19x
Capital structure 93% equity / 7% debt · EV / Revenue 7.36x · EV / EBITDA 17.75x
JNJ carries the larger enterprise value at $693.11B against $5.78B; JNJ trades on the lower EV / Revenue multiple (7.36x vs 8.64x); JNJ on the lower EV / EBITDA (17.75x vs 23.19x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Qualys, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Johnson & Johnson · implied price per share
Bear
$93.96
Base
$115.89
Bull
$146.14
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.17x
0.61x
Net debt / EBITDA
Leverage against operating earnings
-0.62x
0.76x
Cash and equivalents
Liquid reserves on the balance sheet
$250.26M
$20.10B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
CrowdStrike Holdings, Inc.
QLYS vs CRWD
Okta, Inc.
QLYS vs OKTA
Gen Digital Inc.
QLYS vs GEN
Palo Alto Networks Inc
QLYS vs PANW
Fortinet, Inc.
QLYS vs FTNT
Zscaler, Inc.
QLYS vs ZS
Pfizer Inc.
QLYS vs PFE
Eli Lilly and Company
QLYS vs LLY
Abbott Laboratories
QLYS vs ABT
Amgen Inc.
QLYS vs AMGN
$95.20M
$49.94B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.